Sidekick Health ha anunciat el tancament d’una ronda de finançament de Serie B de 55 milions de dòlars. La ronda l’ha liderat la firma londinenca d’inversió Novator Ventures, amb la participació de Sabadell Asabys, Wellington Partners i Frumtak Ventures, i ha comptat també amb l’entrada d’un corporatiu estratègic americà que serà anunciat més endavant.

Integra Therapeutics, a biotechnology company that creates next-generation gene writing tools, member of CataloniaBio & HealthTech, announced today that Dr Mark Bonyhadi has been appointed to its Board of Directors as an independent director.

The President of the Generalitat de Catalunya, Pere Aragonès, has inaugurated the Avinent Hub, the new  innovation and production center of the Avinent group, a leading company in the manufacture of products with the highest demand for the medical sector. The new building, of 8,000 m2 and which has involved an investment of € 10 million, reflects the ambition, modernity, and technological spirit of the Catalan firm, based in Santpedor. This expansion aims to ensure the future capacity for business growth and go from € 35 million in turnover in the last year to € 50 million in 2025.

Laboratoris Reig Jofre, l’empresa farmacèutica cotitzada al mercat continu de la borsa espanyola i membre de CataloniaBio & HealthTech, ha rebut la visita del president de la Generalitat de Catalunya, Pere Aragonès, a la seva nova planta d’última generació de productes injectables d’ús hospitalari. L’acte ha comptat també amb la participació de la presidenta i el conseller delegat de Reig Jofre, Isabel Reig i Ignasi Biosca, i de l’alcaldessa de Sant Joan Despí, Belén García.

Ditec Medical, a specialist in the digitization of operating theatres with a link to the audiovisual sector, has just launched its own line of multimedia medical carts for the health sector. A new generation of high-performance, state-of-the-art solutions that are easy to use for the general public.

The biotechnology company Onalabs, a member of CataloniaBio & HealthTech, has closed its first round of financing, raising 1.2 million euros. The company, dedicated to the development of medical devices capable of monitoring the physical and biochemical parameters of the skin, has carried out the round through the crowdfunding platform Capital Cell, also a member.

The consultancy firm GENESIS Biomed, CataloniaBio & HealthTech  member, together with FI Group, have created GENESIS Tech Transfer Boost, a new investment vehicle initially endowed with €1M that will invest in early-stage projects in the field of health research.

Mediktor, the AI medical assistant for triage and pre-diagnosis, has appointed Amit Jain as Chairman of the board. He will be actively involved in developing and guiding Mediktor’s commercial strategy for the US Market.

Specipig, CataloniaBio & HealthTech member, has expanded its facilities, in the Barcelona area, to a total surface area of 2,400 square metres in order to boost its capacity as a benchmark preclinical Contract Research Organization (CRO) in the biomedical sector. The company currently has three fully equipped operating sites, one analytical laboratory, research facilities and offices, and a team of over 20 qualified professionals.

Anaconda Biomed, a spin-off from the Vall d’Hebron Research Institute (VHIR) and members of CataloniaBio & HealthTech, has completed the clinical trial it was conducting for Advanced Neurovascular Access (ANA), its next-generation catheter. The product could hit the market next year.

The Girona-based company mjn-neuro is one of the start-ups benefiting from EIT Health’s Start-up Amplifier Instrument program, an initiative that helps start-ups gain access to new European markets. The 2.76 million euros grant will allow mjn-neuro to enter the European market with its mjn-SERAS device, the first product worldwide capable of warning in advance of a crisis of epilepsy.

The pharmaceutical company Gebro Pharma and the start-up HumanITcare have signed an agreement for the entry of the pharmaceutical company into the telemedicine sector, specifically in the monitoring of asthma patients. Both companies are members of CataloniaBio & HealthTech.

Onalabs has been recognized as an innovative technology company in the first edition of the DRAC Awards. The RAC1 station has organized the first edition of the DRAC Awards with the aim of recognizing the people, initiatives, organizations, and projects that have driven change and improvement in society and that have become a benchmark in the last year.

Asphalion announced the release of its 2022 Corporate Social Responsibility (CSR) plan, demonstrating its CSR commitment to meet this year’s sustainability goals built on three pillars: health and well-being, gender equality and responsible production and consumption. The plan highlights the priority areas where  Asphalion will set its focus. These are aligned with the 17 UN 2030 sustainable  development goals.

The spin-off INBRAIN  Neuroelectronics has signed an agreement for the exploitation and development of three patents and an industrial secret, of which the Barcelona Institute of Microelectronics (IMB-CNM) of the CSIC, the Institut Català de Nanociència i Nanotecnologia (ICN2), the Catalan Institution for Research and Advanced Studies (ICREA) and the CIBER (CIBER-BBN area). The Autonomous University of Barcelona (UAB) and the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) are also holders. This is a technology transfer success in a  public-private collaboration with multiple research institutions.

El fons ICF Capital Expansió II ha invertit 2,5 milions d’euros a l’empresa gironina TECNIC Bioprocess Equipment Manufacturing especialitzada en el desenvolupament d’equips per processos biotecnològics. L’operació s’ha fet a través d’una ampliació de capital amb l’objectiu de millorar la competitivitat de l’empresa i impulsar el seu creixement internacional.

Integra Therapeutics, a biotechnology company that creates next generation gene writing tools, a CataloniaBio & HealthTech  member, has closed an additional €1.5-million investment from venture capital firm Columbus Venture Partners. This investment comes on top of the €4.5 million Integra Therapeutics raised last December from AdBio Partners, Invivo Capital and Takeda Ventures and completes its seed round in line with the company’s set goals.

DevsHealth, the deeptech companyand a CataloniaBio &HealthTech member, and FundacióLluita contra la Sida i les Malalties Infeccioses havestarted a joint project to design new molecules aimed against SARS-CoV-2, whichwill provide effective and affordable treatments and reduce the progression ofthe disease and severe cases. The joint project will allow both parties touse DevsHealth DeepTech processes to design new candidate molecules, as well asthe expertise in drug validation and evaluation provided by Fundació.This will increase the success rates and efficacy of the future drugs againstSARS-CoV-2.

The last two years have unquestionably made a difference in the biomedical and health sector, and Catalonia has not been an exception. The COVID-19 pandemic has highlighted the importance of a commitment to knowledge and innovation industry, the need to have a local industrial network, while acknowledging that biotechnology and medical technology is a rising sector. This atmosphere of optimism about the situation of the sector has been present in the celebration of the Night of CataloniaBio & Healthtech, the annual meeting of the health and life sciences sector in Catalonia, which was held this March 22 at the Palau de la Música in Barcelona. The event was attended by the Catalan Minister of Health, Josep Maria Argimon, and more than 250 members of the association, including entrepreneurs, executives, and investors in the sector.

CataloniaBio & HealthTech ha lliurat el Premi Bioèxit a la biotecnològica IMIDomics per l’exemplar translació entre la clínica i l’empresa i, en especial, per les fites  assolides en finançament durant el 2021 en l’àmbit de la biomedicina i  la salut a Catalunya. L’acte d’entrega s’ha celebrat aquest 22 de març en el marc de la Nit de CataloniaBio & HealthTech al Palau de la Música de Barcelona, al qual hi ha assistit el conseller de Salut, Josep Maria Argimon, i més de 250 membres de l’associació, entre emprenedors, executius i inversors del sector.